The value of serum ACE and lysozyme and CSF ACE are limited for diagnosing neurosarcoidosis: sensitivity of serum ACE is 75% in untreated and 35% in treated patients, sensitivity of lysozyme 46% and sensitivity and specificity of CSF ACE is 67% and 67% respectively.1 This evidence concerns the gene ACE and neurosarcoidosis.